138 related articles for article (PubMed ID: 20887225)
1. Innate immunity in resistance to HIV infection.
Biasin M; Clerici M; Piacentini L
J Infect Dis; 2010 Nov; 202 Suppl 3():S361-5. PubMed ID: 20887225
[TBL] [Abstract][Full Text] [Related]
2. Innate immunity in the control of HIV/AIDS: recent advances and open questions.
Ploquin MJ; Jacquelin B; Jochems SP; Barré-Sinoussi F; Müller-Trutwin MC
AIDS; 2012 Jun; 26(10):1269-79. PubMed ID: 22472855
[TBL] [Abstract][Full Text] [Related]
3. Vif and Apobec3G in the innate immune response to HIV: a tale of two proteins.
Farrow MA; Sheehy AM
Future Microbiol; 2008 Apr; 3(2):145-54. PubMed ID: 18366335
[TBL] [Abstract][Full Text] [Related]
4. Enhancing immunity to HIV through APOBEC.
Harris RS
Nat Biotechnol; 2008 Oct; 26(10):1089-90. PubMed ID: 18846074
[No Abstract] [Full Text] [Related]
5. The emerging role of innate immunity in protection against HIV-1 infection.
Lehner T; Wang Y; Pido-Lopez J; Whittall T; Bergmeier LA; Babaahmady K
Vaccine; 2008 Jun; 26(24):2997-3001. PubMed ID: 18180080
[TBL] [Abstract][Full Text] [Related]
6. [Cellular restriction factors that inhibit human immunodeficiency virus replication: new strategies in antiretroviral therapy].
Moreno-Valencia Y; Alvarez-García LX; Vázquez-Pérez JA
Rev Invest Clin; 2014; 66(4):359-68. PubMed ID: 25695302
[TBL] [Abstract][Full Text] [Related]
7. Induction of innate immunity in control of mucosal transmission of HIV.
Wang Y; Lehner T
Curr Opin HIV AIDS; 2011 Sep; 6(5):398-404. PubMed ID: 21734563
[TBL] [Abstract][Full Text] [Related]
8. Natural resistance to HIV infection: The Vif-APOBEC interaction.
Malim MH
C R Biol; 2006 Nov; 329(11):871-5. PubMed ID: 17067930
[TBL] [Abstract][Full Text] [Related]
9. Damage control: how HIV survives the editor APOBEC3G.
Croxford JL; Gasser S
Nat Immunol; 2011 Sep; 12(10):925-7. PubMed ID: 21934670
[TBL] [Abstract][Full Text] [Related]
10. Not just sheer luck! Immune correlates of protection against HIV-1 infection.
Piacentini L; Fenizia C; Naddeo V; Clerici M
Vaccine; 2008 Jun; 26(24):3002-7. PubMed ID: 18180082
[TBL] [Abstract][Full Text] [Related]
11. Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells.
Chen K; Huang J; Zhang C; Huang S; Nunnari G; Wang FX; Tong X; Gao L; Nikisher K; Zhang H
J Virol; 2006 Aug; 80(15):7645-57. PubMed ID: 16840343
[TBL] [Abstract][Full Text] [Related]
12. A new approach to an AIDS vaccine: creating antibodies to HIV vif will enable apobec3G to turn HIV-infection into a benign problem.
Jeffrey Fessel W
Med Hypotheses; 2005; 64(2):261-3. PubMed ID: 15607551
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cells in HIV-1 infection: a double-edged sword.
Funke J; Dürr R; Dietrich U; Koch J
AIDS Rev; 2011; 13(2):67-76. PubMed ID: 21587340
[TBL] [Abstract][Full Text] [Related]
14. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.
Gonzalez VD; Landay AL; Sandberg JK
Clin Immunol; 2010 Apr; 135(1):12-25. PubMed ID: 20100670
[TBL] [Abstract][Full Text] [Related]
15. Tactics used by HIV-1 to evade host innate, adaptive, and intrinsic immunities.
Lu L; Yu F; DU LY; Xu W; Jiang SB
Chin Med J (Engl); 2013 Jun; 126(12):2374-9. PubMed ID: 23786957
[TBL] [Abstract][Full Text] [Related]
16. The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals.
Ulenga NK; Sarr AD; Hamel D; Sankale JL; Mboup S; Kanki PJ
AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1285-90. PubMed ID: 18851679
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients.
Monteleone K; Di Maio P; Cacciotti G; Falasca F; Fraulo M; Falciano M; Mezzaroma I; D'Ettorre G; Turriziani O; Scagnolari C
Med Microbiol Immunol; 2014 Jun; 203(3):207-16. PubMed ID: 24553842
[TBL] [Abstract][Full Text] [Related]
18. CCR6 ligands inhibit HIV by inducing APOBEC3G.
Lafferty MK; Sun L; DeMasi L; Lu W; Garzino-Demo A
Blood; 2010 Feb; 115(8):1564-71. PubMed ID: 20023216
[TBL] [Abstract][Full Text] [Related]
19. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.
Sheehy AM; Gaddis NC; Malim MH
Nat Med; 2003 Nov; 9(11):1404-7. PubMed ID: 14528300
[TBL] [Abstract][Full Text] [Related]
20. APOBEC3G levels predict rates of progression to AIDS.
Jin X; Wu H; Smith H
Retrovirology; 2007 Mar; 4():20. PubMed ID: 17374143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
